Fig. 1.
Fig. 1. Establishment of anti–MD-1 mAbs. / The specificity of anti–MD-1 mAbs is shown with flow cytometry staining of Ba/F3 cells expressing either mouse RP105/mouse MD-1 (A, D, G), human RP105/mouse MD-1 (B, E, H), or human RP105/human MD-1 (C, F, I). These cells were stained with the mAbs to either mouse RP105, RP/14 (A-C), mouse MD-1, MD14 (D-F), or human RP105, MHR73 (G-I). FITC-labeled goat anti–rat IgG or anti–mouse IgG was used for the second reagent. Gray lines depict staining with the second antibody alone.

Establishment of anti–MD-1 mAbs.

The specificity of anti–MD-1 mAbs is shown with flow cytometry staining of Ba/F3 cells expressing either mouse RP105/mouse MD-1 (A, D, G), human RP105/mouse MD-1 (B, E, H), or human RP105/human MD-1 (C, F, I). These cells were stained with the mAbs to either mouse RP105, RP/14 (A-C), mouse MD-1, MD14 (D-F), or human RP105, MHR73 (G-I). FITC-labeled goat anti–rat IgG or anti–mouse IgG was used for the second reagent. Gray lines depict staining with the second antibody alone.

Close Modal

or Create an Account

Close Modal
Close Modal